共 50 条
- [24] 4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
- [25] 4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry Allergy, Asthma & Clinical Immunology, 13
- [30] Omalizumab as add-on therapy in a patient with severe asthma and OSA RESPIROLOGY CASE REPORTS, 2020, 8 (02):